A Study of TopSpin360 Training Device
The Effectiveness of a Novel Neck Training Device on Objective Neck Strength and Cognitive Measures in Junior A Hockey Players
1 other identifier
interventional
60
1 country
1
Brief Summary
This research is being done to investigate the novel neck strengthening device, TopSpin360 and its effectiveness on measures of neck strength and cognitive function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Sep 2023
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2023
CompletedFirst Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
September 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedOctober 24, 2025
October 1, 2025
2.6 years
September 18, 2023
October 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Change in peak force
Measured by a neck isometric device, maximal load in kilograms that could be applied to head before deviation from neutral position.
Baseline, post-season (approximately 6 months)
Change in normalized peak force
Measured by a neck isometric device, peak force divided by participant weight in kilograms.
Baseline, post-season (approximately 6 months)
Change in force steadiness
Measured by a neck isometric device, average peak force.
Baseline, post-season (approximately 6 months)
Change in rate of force development (RFD)
Automatically collected by the TopSpin360 device, the multi-planar rate of force development (RFD) in pounds of force per second collected in both clockwise and counterclockwise.
Baseline, post-season (approximately 6 months)
Change in visuo-motor reaction time
Measured by a neck isometric device, reported in milliseconds (ms)
Baseline, post-season (approximately 6 months)
Change in blood biomarker levels
Blood will be at a biomarker level. We will investigate 5 different markers: NfL, SNCB, vWF, SNCA, and BDNF. Each biomarker will be measured in Nanograms per Milliliter (ng/ml).
Baseline, post-season (approximately 6 months)
Change in salivary biomarkers
Salivary biomarkers are relatively new and we will investigate to see if NfL, SNCB, vWF, SNCA, and BDNF. Each biomarker will be measured in Nanometer per milliliter (ng/ml).
Baseline, post-season (approximately 6 months)
Change in N100 Amplitude
Electroencephalograph (EEG) recording of brain electrical activity N100 potential amplitude. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.
Baseline, post-season (approximately 6 months)
Change in N100 Latency
Electroencephalograph (EEG) recording of brain electrical activity N100 potential latency. Increased latencies are indicative of slower responses. Obtained by EEG recording of N100 potential amplitude. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.
Baseline, post-season (approximately 6 months)
Change in P300 Amplitude
Electroencephalograph (EEG) recording of brain electrical activity P300 potential amplitude. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.
Baseline, post-season (approximately 6 months)
Change in P300 Latency
Electroencephalograph (EEG) recording of brain electrical activity P300 potential latency. Increased latencies are indicative of slower responses. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores
Baseline, post-season (approximately 6 months)
Change in N400 Amplitude
Electroencephalograph (EEG) recording of brain electrical activity N400 potential amplitude. Increased amplitudes are indicative of larger signals. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.
Baseline, post-season (approximately 6 months)
Change in N400 Latency
Electroencephalograph (EEG) recording of brain electrical activity N400 potential latency. Increased latencies are indicative of slower responses. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.
Baseline, post-season (approximately 6 months)
Secondary Outcomes (1)
Change in King-Devick Test (KDT) scores
Baseline, post-season (approximately 6 months)
Study Arms (2)
Control Group
NO INTERVENTIONSubjects will receive no intervention for the duration of the hockey season.
TopSpin360 Intervention Group
EXPERIMENTALSubjects will use TopSpin360, twice- weekly and use for the duration of the hockey season.
Interventions
Helmet training device used to train head to stay stable during jarring impacts through dynamic and multi-planar neck strengthening.
Eligibility Criteria
You may qualify if:
- Fluent English Speaker.
- Medically cleared to play ice hockey.
You may not qualify if:
- Clinically documented hearing issues.
- In-ear hearing aid or cochlear implant.
- Implanted pacemaker or defibrillator.
- Metal or plastic implants in skull. lack of verbal fluency in the English language.
- History of seizures.
- Allergy to rubbing alcohol or EEG gel.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Mario Hevesi, MD
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 18, 2023
First Posted
September 25, 2023
Study Start
September 9, 2023
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
October 24, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share